The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare cardiovascular diseases. Pulmonary arterial hypertension (PAH) is a progressive condition characterized by elevated blood pressure in the arteries that supply the lungs, which can lead to heart failure if left …